Literature DB >> 6787829

Plasma angiotensin II concentrations in diabetic ketoacidosis and in hyperosmolar non-ketotic hyperglycemia.

P A Sullivan, H Gonggrijp, M J Crowley, J B Ferriss, D J O'Sullivan.   

Abstract

Plasma angiotensin II concentrations were measured in 14 patients in diabetic ketoacidosis and in two patients with hyperosmolar non-ketotic hyperglycemia, before treatment and again when blood glucose control was restored. In the ketoacidosis group plasma angiotensin II before treatment was markedly raised in all patients with otherwise uncomplicated diabetes, but was within the normal range in some patients with long-term complications such as neuropathy, retinopathy and nephropathy. Mean angiotensin II before treatment was significantly higher in otherwise uncomplicated patients than in those with long-term complications. However, plasma angiotensin II decreased with improved control in all. Angiotensin II levels did not correlate with indices of rehydration such as changes in blood urea, packed cell volume and calculated changes in plasma volume. There was, however, a significant negative association between pre-treatment angiotensin II and pH. Two patients with hyperosmolar non-ketotic hyperglycemia were more dehydrated but less acidotic. Pre-treatment angiotensin II in each was well below the mean of the ketoacidosis group. These data are further evidence that the renin-angiotensin system may be imparied in diabetics with long-term complications. In addition, they suggest that factors other than fluid depletion are also important in activating the renin-angiotensin system in uncontrolled diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787829     DOI: 10.1007/BF02098999

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  23 in total

1.  Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

Authors:  G Düsterdieck; G McElwee
Journal:  Eur J Clin Invest       Date:  1971-11       Impact factor: 4.686

2.  Evaluation of hemoconcentration from hematocrit measurements.

Authors:  W Van Beaumont
Journal:  J Appl Physiol       Date:  1972-05       Impact factor: 3.531

3.  Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man.

Authors:  H Gavras; D Kremer; J J Brown; B Gray; A F Lever; R F MacAdam; A medina; J J Morton; J I Robertson
Journal:  Am Heart J       Date:  1975-03       Impact factor: 4.749

4.  Haemodynamic characteristics of low-renin hypertension.

Authors:  M A Schalekamp; W H Birkenhäger; G A Zaal; G Kolsters
Journal:  Clin Sci Mol Med       Date:  1977-04

5.  Regulation of renin release by calcium and ammonium ions in normal man.

Authors:  E S Kisch; R G Dluhy; G H Williams
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

6.  Cardiovascular effects of insulin: plasma volume changes in diabetics.

Authors:  J D Mackay; H Hayakawa; P J Watkins
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

7.  Plasma renin activity and hypertension in diabetes mellitus.

Authors:  A R Christlieb; A Kaldany; J A D'Elia
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

8.  Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.

Authors:  A R Christlieb; J P Assal; N Katsilambros; G H Williams; G P Kozak; T Suzuki
Journal:  Diabetes       Date:  1975-02       Impact factor: 9.461

9.  Reciprocal relation between renin dependency and sodium dependency in essential hypertension.

Authors:  H Gavras; A B Ribeiro; I Gavras; H R Brunner
Journal:  N Engl J Med       Date:  1976-12-02       Impact factor: 91.245

10.  Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects.

Authors:  N J Christensen
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  1 in total

1.  Hyperaldosteronism in ketoacidosis and in poorly controlled non-ketotic diabetes.

Authors:  C Quigley; P A Sullivan; H Gonggrijp; M J Crowley; J B Ferriss; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1982-05       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.